Clinical Application of Percutaneous Gallbladder Drainage in Severe Acute Pancreatitis
10.12007/j.issn.0258-4646.2018.03.012
- VernacularTitle:经皮胆囊穿刺引流术辅助治疗重症急性胰腺炎的临床应用价值
- Author:
Feng XIE
1
;
Fang ZHU
;
Hongyan WANG
;
Zhengrong LIU
;
Xiaodan ZHAO
;
Xiaogang FAN
;
Hongmin HAN
Author Information
1. 中国医科大学人民医院核医学科
- Keywords:
percutaneous gallbladder drainage;
severe acute pancreatitis;
mortality;
systemic complication;
local complication
- From:
Journal of China Medical University
2018;47(3):244-246
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of percutaneous gallbladder drainage in the treatment of severe acute pancreatitis(SAP). Methods A total of 65 patients treated for SAP in our hospital between January 2014 and April 2017 were analyzed retrospectively. The patients were divided into a gallbladder puncture group and a control group. Follow-up was performed for at least 6 months to monitor mortality and the incidence of complications, including pancreatic abscess, pseudocyst, renal failure, respiratory failure, heart failure, gastrointestinal bleeding, sepsis, and disseminated intravascular coagulation (DIC), The differences in mortality and complication rates between the two groups were statistically analyzed. Results Mortality in the gallbladder puncture group was significantly lower than in the control group (P ＜ 0. 05); the incidence of renal failure, respiratory failure, heart failure, gastrointestinal bleeding, and sepsis in the gallbladder puncture group was lower than in the control group (P ＜ 0. 05); the incidence of pancreatic abscess and pseudocyst in the gallbladder puncture group was similar to that in the control group, showing no significant difference (P ＞ 0. 05); the incidence of DIC in the gallbladder puncture group was lower than in the control group, but the difference was not statistically significant (P ＞ 0. 05). Conclusion Percutaneous gallbladder drainage can effectively reduce the incidence of renal failure, respiratory failure, heart failure, gastrointestinal bleeding, and sepsis in SAP, thereby reducing mortality. However, the incidence of DIC, pancreatic abscess, and pseudocyst is not reduced.
